回盛生物 (300871.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

现金流量表(回盛生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 700,635,232.40437,232,536.54219,059,236.191,033,617,366.49693,909,348.87481,808,713.78247,206,094.98
 收到的税费返还(元) 2,415,943.14896,487.2157,230.801,203,167.459,310,263.918,358,441.34620,988.20
 收到其他与经营活动有关的现金(元) 24,628,102.9312,842,903.705,211,477.2446,773,598.6141,332,201.2725,246,643.067,805,626.18
 经营活动现金流入小计(元) 727,679,278.47450,971,927.45224,327,944.231,081,594,132.55744,551,814.05515,413,798.18255,632,709.36
 购买商品、接受劳务支付的现金(元) 537,880,787.04357,476,908.21200,219,484.04737,466,292.61505,647,676.19378,711,320.04199,112,678.09
 支付给职工以及为职工支付的现金(元) 102,566,365.5872,992,988.1241,194,936.06134,992,583.16103,186,997.0373,754,965.6143,500,313.03
 支付的各项税费(元) 23,901,686.7715,612,922.2811,870,404.8942,449,021.4933,238,724.1623,980,381.3710,657,144.95
 支付其他与经营活动有关的现金(元) 56,219,795.4535,898,209.2117,322,612.8973,766,889.2945,418,203.5532,945,589.6819,542,807.60
 经营活动现金流出小计(元) 720,568,634.84481,981,027.82270,607,437.88988,674,786.55687,491,600.93509,392,256.70272,812,943.67
 经营活动产生的现金流量净额(元) 7,110,643.63-31,009,100.37-46,279,493.6592,919,346.0057,060,213.126,021,541.48-17,180,234.31
二、投资活动产生的现金流量
 收回投资收到的现金(元) 525,530,535.54320,000,000.00180,000,000.001,055,374,911.02745,374,911.02580,374,911.02350,374,911.02
 取得投资收益收到的现金(元) 7,473,427.965,790,251.363,372,284.7014,158,896.347,870,257.444,491,488.281,899,024.13
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 92,440.7790,000.0080,000.00-1,672.98--
 投资活动现金流入小计(元) 533,096,404.27325,880,251.36183,452,284.701,069,533,807.36753,246,841.44584,866,399.30352,273,935.15
 购建固定资产、无形资产和其他长期资产支付的现金(元) 168,406,143.06116,987,693.1679,380,481.93184,311,837.97143,073,702.37105,936,496.8360,413,304.28
 投资支付的现金(元) 491,434,530.68270,403,995.14180,403,995.14985,526,038.15785,374,911.02595,374,911.02380,374,911.02
 投资活动现金流出小计(元) 659,840,673.74387,391,688.30259,784,477.071,169,837,876.12928,448,613.39701,311,407.85440,788,215.30
 投资活动产生的现金流量净额(元) -126,744,269.47-61,511,436.94-76,332,192.37-100,304,068.76-175,201,771.95-116,445,008.55-88,514,280.15
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) 685,001.00300,000.00-----
  其中:子公司吸收少数股东投资收到的现金(元) 685,001.00300,000.00-----
 取得借款收到的现金(元) 360,000,000.00290,000,000.00170,000,000.00210,849,666.65170,000,000.00140,000,000.00106,340,072.90
 收到其他与筹资活动有关的现金(元) 62,740,242.0053,746,379.0032,776,473.0053,917,809.0064,000,720.0068,628,706.9030,000,000.00
 筹资活动现金流入小计(元) 423,425,243.00344,046,379.00202,776,473.00264,767,475.65234,000,720.00208,628,706.90136,340,072.90
 偿还债务支付的现金(元) 339,620,272.90156,340,072.9090,000,000.00244,301,123.13210,000,000.00112,634,408.4670,000,000.00
 分配股利、利润或偿付利息支付的现金(元) 50,820,249.6547,544,117.821,232,097.2358,632,786.3252,709,356.3450,614,786.171,744,954.03
 支付其他与筹资活动有关的现金(元) 3,335,138.452,399,670.0016,340,072.903,309,930.0012,344,997.323,309,930.00-
 筹资活动现金流出小计(元) 393,775,661.00206,283,860.72107,572,170.13306,243,839.45275,054,353.66166,559,124.6371,744,954.03
 筹资活动产生的现金流量净额(元) 29,649,582.00137,762,518.2895,204,302.87-41,476,363.80-41,053,633.6642,069,582.2764,595,118.87
四、汇率变动对现金及现金等价物的影响(元) -178,476.97-313,967.68-355,524.40-232,826.75154.9812,560.54-34,369.89
五、现金及现金等价物净增加额(元) -90,162,520.8144,928,013.29-27,762,907.55-49,093,913.31-159,195,037.51-68,341,324.26-41,133,765.48
 加:期初现金及现金等价物余额(元) 229,512,289.39229,512,289.39229,512,289.39278,606,202.70278,606,202.70278,606,202.70278,606,202.70
 期末现金及现金等价物余额(元) 139,349,768.58274,440,302.68201,749,381.84229,512,289.39119,411,165.19210,264,878.44237,472,437.22
补充资料:
 净利润(元) --51,879,057.19-16,780,818.77-15,897,944.16-
 资产减值准备(元) --2,867,313.92-2,643,840.37-477.36-
 固定资产和投资性房地产折旧(元) -53,843,444.96-117,687,382.00-52,793,361.69-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) -53,843,444.96-117,687,382.00-52,793,361.69-
 无形资产摊销(元) -1,451,495.17-2,701,918.55-1,369,187.47-
 长期待摊费用摊销(元) -427,291.73-632,567.45-82,595.88-
 固定资产报废损失(元) -71,868.12-666,534.73-291,376.09-
 公允价值变动损失(元) -49,002,063.88--12,252,419.77--3,858,963.41-
 财务费用(元) -20,652,613.06-28,215,682.33-19,987,374.38-
 投资损失(元) --5,747,399.98--13,122,321.17--3,189,297.17-
 递延所得税(元) --13,325,431.81--10,299,312.68--1,403,418.63-
  其中:递延所得税资产减少(元) --3,016,934.72--8,743,526.96--371,309.41-
 递延所得税负债增加(元) --10,308,497.09--1,555,785.72--1,032,109.22-
 存货的减少(元) --63,377,164.98--28,058,565.25--52,403,670.06-
 经营性应收项目的减少(元) -31,468,779.35--109,819,679.59--19,560,615.12-
 经营性应付项目的增加(元) --52,469,358.46-71,981,084.43--10,698,798.46-
 其他(元) -1,739,069.70---6,713,987.30-
 现金的期末余额(元) -274,440,302.68-229,512,289.39-210,264,878.44-
 减:现金的期初余额(元) -229,512,289.39-278,606,202.70-278,606,202.70-
 现金及现金等价物的净增加额(元) -44,928,013.29--49,093,913.31--68,341,324.26-
公告日期 2024-10-302024-08-282024-04-252024-04-252023-10-302023-08-292023-04-27
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院